PeptidePedia The community reference

Talk:Xi'an Mokemei Biotechnology

Discussion page·3 threads·1 archive

This article is within the scope of Project:Vendor notability, which sets out when a supplier organisation warrants an article and what such an article may not contain.
Supplier articles attract promotional editing. Editors with a commercial relationship with the subject must disclose it and propose changes here rather than making them — see Project:Conflict of interest.

This is the discussion page for the article Xi'an Mokemei Biotechnology. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

How should the lot-mismatch reports be presented?RfC

Request for comment. This discussion is advertised to the wider editorial community. Uninvolved editors are asked to comment on the question as framed in the opening statement, not on the conduct of the participants.

Request for comment. §Operations records two purchaser reports of a certificate whose lot identifier did not match the vial label. Two reports out of a set of several hundred.

Question: does recording that serve the reader, or does it give two anecdotes the weight of a finding? The competing considerations are verifiability (the reports exist and are attributable) and undue weight (two is not a pattern). — RfC_Rasmus (talk) 10:44, 2 December 2025 (UTC)

Record it, with the count stated. A traceability failure is qualitatively different from a purity variance: it means the document does not describe the object. Two instances is not a pattern and the article says so, but a reader deciding what to check on arrival is better off knowing that this is a thing that has happened. — LotTraceLuka (talk) 13:21, 2 December 2025 (UTC)

Record it. My test for undue weight is whether the count and the denominator are both visible. They are. What would be undue is a section heading about it, or its appearing in the lead. — NPOV_Nadia (talk) 09:37, 3 December 2025 (UTC)

Record with reservation. I accept the reasoning, but note that we do not have comparable data for the other nineteen organisations — nobody has systematically asked purchasers whether lot numbers matched. So this article carries an observation the others do not, and a reader may read its absence elsewhere as absence of the problem. — BalanceBirdie (talk) 15:02, 4 December 2025 (UTC)

Reading consensus as record it, with the count and denominator visible, and taking Birdie's point as an action rather than an objection: the asymmetry across articles is a real problem and I have added it to the working-group list. — RfC_Rasmus (talk) 11:19, 11 December 2025 (UTC)

Standing note: what this article may not containResolved

Placing the standing note at the top of every supplier talk page so it does not have to be re-argued. Under Project:Vendor notability a supplier article may not contain: a price, an offer, a discount, a price list, any contact detail, or a shipping-outcome claim not attributed to a source.

Additions of any of those are removed on sight and are not a content dispute. — NPOV_Nadia (talk) 09:12, 4 July 2024 (UTC)

Support, and worth adding the reason rather than only the rule: each of those items turns a reference entry into a sales listing, and the moment one article carries them every other organisation has a grievance. — CoI_Corin (talk) 11:48, 4 July 2024 (UTC)

Support. I would add "adjectives not attributable to a source" to the list, which is the softer version of the same problem and much the commonest. — Hedgerow_Hal (talk) 10:23, 5 July 2024 (UTC)

Added to the standing note, so that it does not have to be argued again on each of the twenty pages. ✓ ResolvedNPOV_Nadia (talk) 08:57, 6 July 2024 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 11 December 2025, by RfC_Rasmus. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).